The β2 adrenoreceptor agonist salbutamol, a brain-penetrant asthma medication, appears to reduce the risk of developing Parkinson’s disease, possibly through the epigenetic suppression of SNCA—the gene that encodes α-synuclein, according to a study.
Virtual reality (VR) seems to be more effective than standard of care (SOC) in reducing pain and anxiety in children undergoing a routine blood draw, a recent randomized controlled trial (RCT) has shown.
Patients with systemic lupus erythematosus (SLE) are prone to have cognitive impairment (CI), and the Montreal Cognitive Assessment (MoCA) appears to be a useful tool for detecting CI in SLE, according to a recent study. In addition, CI is less likely to occur in patients with more years of education.
In sedentary subjects with impaired glucose tolerance, short-term exercise reduces the insulin-stimulated glucose uptake (GU) of the brain in all regions except the occipital cortex, a recent study shows.
Dysfunctional neurotransmission of substance P within the medulla appears to contribute to sudden infant death syndrome (SIDS) by causing abnormal cardiorespiratory reflexes in response to stimuli such as hypoxia during sleep, a recent study has found.
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
White matter (WM) integrity in HIV-infected children is compromised despite early antiretroviral therapy (ART) and viral load (VL) suppression, with damage persisting at 5 years of age and evidence of new damage present, a recent study has shown.